Clinical Evaluation of a Recombinant Factor VIII Preparation (Kogenate) in Previously Untreated Patients with Hemophilia A-Reference-Cited by-同舟云学术

Clinical Evaluation of a Recombinant Factor VIII Preparation (Kogenate) in Previously Untreated Patients with Hemophilia A

Published:2003-12 Issue:5 Volume:78 Page:467-474
ISSN:0925-5710
Container-title:International Journal of Hematology
language:en
Short-container-title:Int J Hematol

Author:

Yoshioka A., ,Fukutake K.,Takamatsu J.,Shirahata A.

Publisher

Springer Science and Business Media LLC

Subject

Hematology

Link

http://link.springer.com/article/10.1007/BF02983823/fulltext.html

Reference24 articles.

1. Gitschier J, Wood WI, Goralka TM, et al. Characterization of the human factor VIII gene.Nature. 1984;312:326–330.

2. Wood WI, Capon DJ, Simonsen CC, et al. Expression of active human factor VIII from recombinant DNA clones.Nature. 1984;312:330–337.

3. Schwartz RS, Abildgaard CF, Aledort LM, et al. Human recombinant DNA-derived antihemophilic factor (factor VIII) in the treatment of hemophilia A: Recombinant Factor VIII Study Group.N Engl J Med. 1990;323:1800–1805.

4. Yoshioka A. Advances in hemophilia and other coagulation disorders: recombinant factor VIII preparations.Int J Pediatr Hematol Oncol. 1994;1:491–497.

5. Fukui H, Yoshioka A, Shima M, et al. Clinical evaluation of recombinant human factor VIII (BAY w 6240) in the treatment of hemophilia A.Int J Hematol. 1991;54:419–427.

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The safety and efficacy of N8-GP (turoctocog alfa pegol) in previously untreated pediatric patients with hemophilia A;Blood Advances;2023-02-21

2. Hemostatic biomaterials to halt non-compressible hemorrhage;Journal of Materials Chemistry B;2022

3. Epidemiological Challenges in Rare Bleeding Disorders: FVIII Inhibitor Incidence in Haemophilia A Patients—A Known Issue of Unknown Origin;International Journal of Environmental Research and Public Health;2020-12-30

4. Safety and efficacy of turoctocog alfa in the prevention and treatment of bleeds in previously untreated paediatric patients with severe haemophilia A: Results from the guardian 4 multinational clinical trial;Haemophilia;2019-12-09

5. Meta-analysis on incidence of inhibitors in patients with haemophilia A treated with recombinant factor VIII products;Blood Coagulation & Fibrinolysis;2017-12